High-dose dual-antibiotic loaded cement for hip hemiarthroplasty in the UK (WHiTE 8): a randomised controlled trial
Read more
Welcome to Oxford Trauma and Emergency Care
Trauma and emergencies are huge issues for patients, the NHS and society more broadly. Oxford Trauma and Emergency Care seeks to improve patient care by designing and testing new treatments and new treatment pathways. We aim to deliver better outcomes for patients and more efficient care within the NHS and other healthcare system worldwide.
We run a number of clinical trials and related studies in trauma and emergency care to guide best practice in the field. Our work informs practice and policy in the NHS and internationally through bodies such as the National Institute for Health and Care Excellence (NICE) guidelines.
Oxford Trauma and Emergency Care is based in the Kadoorie Centre located at the John Radcliffe Hospital, but has collaborations across the University and outside.
Our research focuses on the clinical and cost effectiveness of orthopaedic surgery.
March 2025 TRIAL STATS
Patients recruited
289
Sites with the most recruits in March
Milton Keynes University Hospital with 31
John Radcliffe Hospital with 20
New sites open in March
University College London
University Hospital Southampton
University Hospital Coventry
Work with us
TEAM
RESEARCH
EVENTS
Latest news
New donation secures future of Emergency Medicine research at Oxford
7 August 2024
A new research programme in emergency medicine begins today at the University of Oxford following a donation from the Kadoorie Foundation.
New prediction model could help inform patients of their risks of having shoulder replacement surgery
31 July 2024
A new model to predict the risk of serious complications after shoulder replacement surgery has been developed in a collaboration between researchers from the University of Oxford, University of Bristol, and University of Copenhagen. The model could be an important tool to help both patients and doctors make more informed decisions about this common procedure.
HIPCARE trial launches in the Philippines
22 April 2024
Prof Matt Costa has just returned from the Philippines, where he launched the new HIPCARE trial with co-lead investigator Prof Irewin Tabu. The first of five Low- and Middle-Income Countries (LMIC) in Asia to take part, eight hospitals in the Philippines will start recruiting patients with fragility fractures of the hip to the study within weeks.
MAIN FUNDER
